The effect of co-supplementation with alpha-linolenic acid and L-carnitine in migraine
Phase 3
- Conditions
- Migraine.G43.0Migraine w
- Registration Number
- IRCT20121216011763N57
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Patients who are willing to participate in the study
Migraine diagnosis by a neurologist based on the International Classification of Headache Disorders-3 (ICHD-3)
Age 20 to 50 years
At least one year has passed since the migraine diagnosis
Exclusion Criteria
Migraine with aura
Suffering from cardiovascular diseases, hypertension, diabetes, liver and kidney diseases, malignancies and other neurological disorders
Pregnancy and lactation
Taking nutritional supplements (including riboflavin, feverfew, magnesium and coenzyme Q10 in the last 3 months)
Taking anticoagulants
Following a special diet
Smoking
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method